Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
655,594
-
Share change
-
-106,217,727
-
Total reported value
-
$114,820,000
-
Price per share
-
$175.14
-
Number of holders
-
17
-
Value change
-
-$20,749,012,541
-
Number of buys
-
7
-
Number of sells
-
373
Institutional Holders of SEATTLE GENETICS INC - COM (SGEN) as of Q4 2020
As of 31 Dec 2020,
SEATTLE GENETICS INC - COM (SGEN) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
655,594 shares.
The largest 10 holders included
BOXER CAPITAL, LLC, PARTNERS CAPITAL INVESTMENT GROUP, LLP, Lagoda Investment Management, L.P., Gulf International Bank (UK) Ltd, CIBC WORLD MARKETS CORP, FAIRFIELD, BUSH & CO., DCF Advisers, LLC, Parcion Private Wealth LLC, BADGLEY PHELPS & BELL INC, and XTX MARKETS LLC.
This page lists
17
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.